U.S. Markets open in 8 hrs 46 mins

Vertex Pharmaceuticals Incorporated (VRTX)

NASDAQ Global Select - NASDAQ Global Select Delayed Price. Currency in USD
Add to watchlist
155.48+6.47 (+4.34%)
At close: 4:00PM EDT
People also watch
ALXNREGNBMRNINCYBIIB
Full screen
Previous Close149.01
Open149.19
Bid0.00 x 0
Ask0.00 x 0
Day's Range149.19 - 155.92
52 Week Range71.46 - 167.86
Volume1,659,747
Avg. Volume2,022,051
Market Cap39.2B
Beta1.95
PE Ratio (TTM)216.85
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • See what the IHS Markit Score report has to say about Vertex Pharmaceuticals Inc.
    Markit17 hours ago

    See what the IHS Markit Score report has to say about Vertex Pharmaceuticals Inc.

    Vertex Pharmaceuticals Inc NASDAQ/NGS:VRTX

  • Barrons.comyesterday

    Gilead: Where's the Urgency?

    Gilead Sciences (GILD) has gained 13% during the past three months as investors have started to bet that the beaten-down biotech stock has finally found a bottom. The iShares Nasdaq Biotechnology ETF (IBB) has dipped 0.1% to $303.67.

  • Vertex Pharmaceuticals Incorporated (VRTX) Stock Is Too Expensive
    InvestorPlaceyesterday

    Vertex Pharmaceuticals Incorporated (VRTX) Stock Is Too Expensive

    Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has turned in triple-digit gains so far this year after news that the firm is on the verge of having several new cystic fibrosis treatments FDA approved. At $149.38 per share, VRTX stock is expensive, but the question is whether or not the stock is too expensive. Have we already missed the boat or does the pharmaceutical company really have the growth potential that investors believe it does.